FibroGen Inc (FGEN)
0.31
-0.01
(-3.82%)
USD |
NASDAQ |
Nov 05, 14:50
FibroGen Market Cap: 31.12M for Nov. 5, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 32.36M |
| November 01, 2024 | 32.02M |
| October 31, 2024 | 30.26M |
| October 30, 2024 | 31.91M |
| October 29, 2024 | 30.74M |
| October 28, 2024 | 30.00M |
| October 25, 2024 | 30.92M |
| October 24, 2024 | 32.13M |
| October 23, 2024 | 32.13M |
| October 22, 2024 | 35.17M |
| October 21, 2024 | 37.60M |
| October 18, 2024 | 39.31M |
| October 17, 2024 | 39.66M |
| October 16, 2024 | 37.72M |
| October 15, 2024 | 35.58M |
| October 14, 2024 | 34.45M |
| October 11, 2024 | 35.87M |
| October 10, 2024 | 33.84M |
| October 09, 2024 | 32.90M |
| October 08, 2024 | 32.97M |
| October 07, 2024 | 34.40M |
| October 04, 2024 | 36.82M |
| October 03, 2024 | 40.05M |
| October 02, 2024 | 40.15M |
| October 01, 2024 | 39.36M |
| Date | Value |
|---|---|
| September 30, 2024 | 40.10M |
| September 27, 2024 | 40.80M |
| September 26, 2024 | 39.32M |
| September 25, 2024 | 37.45M |
| September 24, 2024 | 38.52M |
| September 23, 2024 | 37.36M |
| September 20, 2024 | 41.02M |
| September 19, 2024 | 41.77M |
| September 18, 2024 | 42.17M |
| September 17, 2024 | 44.99M |
| September 16, 2024 | 45.40M |
| September 13, 2024 | 47.19M |
| September 12, 2024 | 42.50M |
| September 11, 2024 | 39.80M |
| September 10, 2024 | 40.16M |
| September 09, 2024 | 39.64M |
| September 06, 2024 | 39.16M |
| September 05, 2024 | 42.69M |
| September 04, 2024 | 40.12M |
| September 03, 2024 | 33.33M |
| August 30, 2024 | 36.71M |
| August 29, 2024 | 37.26M |
| August 28, 2024 | 36.67M |
| August 27, 2024 | 38.66M |
| August 26, 2024 | 39.66M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
30.00M
Minimum
Oct 28 2024
5.102B
Maximum
Feb 12 2021
1.716B
Average
1.340B
Median
Jan 25 2022
Market Cap Benchmarks
| Merck & Co Inc | 257.16B |
| Biomarin Pharmaceutical Inc | 12.55B |
| Arbutus Biopharma Corp | 740.97M |
| GlycoMimetics Inc | 25.07M |
| Cidara Therapeutics Inc | 93.96M |
Market Cap Related Metrics
| PS Ratio | 0.1764 |
| Price | 0.31 |
| Earnings Yield | -551.6% |